Intravenous hyperalimentation in inflammatory bowel disease, pancreatitis, and cancer.
D000970:Antineoplastic Agents / Q000494:pharmacology; D005769:Gastrointestinal Motility; D006801:Humans; D007121:Immunocompetence; D007249:Inflammation; D007410:Intestinal Diseases / Q000276:immunology / Q000628:therapy*; D007412:Intestinal Fistula / Q000628:therapy; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000628:therapy; D010195:Pancreatitis / Q000276:immunology / Q000628:therapy*; D010288:Parenteral Nutrition; D010289:Parenteral Nutrition, Total; D010437:Peptic Ulcer / Q000628:therapy; D011182:Postoperative Care; D011878:Radiotherapy
D000970:Antineoplastic Agents